Macrocyclic pyrimidine derivatives
The present invention relates to substituted macrocyclic pyrimidine derivatives of formula (I) wherein the variables have the meanings defined in the claims. The compounds according to the present invention have EF2K inhibitory activity and optionally also Vps34 inhibitory activity. The invention fu...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BERTHELOT DIDIER JEAN-CLAUDE SCHOENJES, BRUNO DIELS GASTON STANISLAS MARCELLA VIELEVOYE, MARC MIPOY, LAURENT EMBRECHTS WERNER CONSTANT JOHAN WILLEMS MARC VROBROWSKI, BRIAN VERSELE MATTHIAS LUC AIME |
| description | The present invention relates to substituted macrocyclic pyrimidine derivatives of formula (I) wherein the variables have the meanings defined in the claims. The compounds according to the present invention have EF2K inhibitory activity and optionally also Vps34 inhibitory activity. The invention further relates to processes for the preparation of such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.
本发明涉及具有式(I)的取代的大环嘧啶衍生物其中变量具有在权利要求中所定义的含义。根据本发明的化合物具有EF2K抑制活性以及任选地还有Vps34抑制活性。本发明进一步涉及用于制备此类新颖化合物的方法、包括所述化合物作为活性成分的药物组合物连同所述化合物作为药剂的用途。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN114213415A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN114213415A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN114213415A3</originalsourceid><addsrcrecordid>eNrjZFDyTUwuyk-uTM7JTFYoqCzKzM1MycxLVUhJLcosSyzJLEst5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hoYmRobGJoamjsbEqAEA52Umfg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Macrocyclic pyrimidine derivatives</title><source>esp@cenet</source><creator>BERTHELOT DIDIER JEAN-CLAUDE ; SCHOENJES, BRUNO ; DIELS GASTON STANISLAS MARCELLA ; VIELEVOYE, MARC ; MIPOY, LAURENT ; EMBRECHTS WERNER CONSTANT JOHAN ; WILLEMS MARC ; VROBROWSKI, BRIAN ; VERSELE MATTHIAS LUC AIME</creator><creatorcontrib>BERTHELOT DIDIER JEAN-CLAUDE ; SCHOENJES, BRUNO ; DIELS GASTON STANISLAS MARCELLA ; VIELEVOYE, MARC ; MIPOY, LAURENT ; EMBRECHTS WERNER CONSTANT JOHAN ; WILLEMS MARC ; VROBROWSKI, BRIAN ; VERSELE MATTHIAS LUC AIME</creatorcontrib><description>The present invention relates to substituted macrocyclic pyrimidine derivatives of formula (I) wherein the variables have the meanings defined in the claims. The compounds according to the present invention have EF2K inhibitory activity and optionally also Vps34 inhibitory activity. The invention further relates to processes for the preparation of such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.
本发明涉及具有式(I)的取代的大环嘧啶衍生物其中变量具有在权利要求中所定义的含义。根据本发明的化合物具有EF2K抑制活性以及任选地还有Vps34抑制活性。本发明进一步涉及用于制备此类新颖化合物的方法、包括所述化合物作为活性成分的药物组合物连同所述化合物作为药剂的用途。</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220322&DB=EPODOC&CC=CN&NR=114213415A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220322&DB=EPODOC&CC=CN&NR=114213415A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BERTHELOT DIDIER JEAN-CLAUDE</creatorcontrib><creatorcontrib>SCHOENJES, BRUNO</creatorcontrib><creatorcontrib>DIELS GASTON STANISLAS MARCELLA</creatorcontrib><creatorcontrib>VIELEVOYE, MARC</creatorcontrib><creatorcontrib>MIPOY, LAURENT</creatorcontrib><creatorcontrib>EMBRECHTS WERNER CONSTANT JOHAN</creatorcontrib><creatorcontrib>WILLEMS MARC</creatorcontrib><creatorcontrib>VROBROWSKI, BRIAN</creatorcontrib><creatorcontrib>VERSELE MATTHIAS LUC AIME</creatorcontrib><title>Macrocyclic pyrimidine derivatives</title><description>The present invention relates to substituted macrocyclic pyrimidine derivatives of formula (I) wherein the variables have the meanings defined in the claims. The compounds according to the present invention have EF2K inhibitory activity and optionally also Vps34 inhibitory activity. The invention further relates to processes for the preparation of such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.
本发明涉及具有式(I)的取代的大环嘧啶衍生物其中变量具有在权利要求中所定义的含义。根据本发明的化合物具有EF2K抑制活性以及任选地还有Vps34抑制活性。本发明进一步涉及用于制备此类新颖化合物的方法、包括所述化合物作为活性成分的药物组合物连同所述化合物作为药剂的用途。</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFDyTUwuyk-uTM7JTFYoqCzKzM1MycxLVUhJLcosSyzJLEst5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hoYmRobGJoamjsbEqAEA52Umfg</recordid><startdate>20220322</startdate><enddate>20220322</enddate><creator>BERTHELOT DIDIER JEAN-CLAUDE</creator><creator>SCHOENJES, BRUNO</creator><creator>DIELS GASTON STANISLAS MARCELLA</creator><creator>VIELEVOYE, MARC</creator><creator>MIPOY, LAURENT</creator><creator>EMBRECHTS WERNER CONSTANT JOHAN</creator><creator>WILLEMS MARC</creator><creator>VROBROWSKI, BRIAN</creator><creator>VERSELE MATTHIAS LUC AIME</creator><scope>EVB</scope></search><sort><creationdate>20220322</creationdate><title>Macrocyclic pyrimidine derivatives</title><author>BERTHELOT DIDIER JEAN-CLAUDE ; SCHOENJES, BRUNO ; DIELS GASTON STANISLAS MARCELLA ; VIELEVOYE, MARC ; MIPOY, LAURENT ; EMBRECHTS WERNER CONSTANT JOHAN ; WILLEMS MARC ; VROBROWSKI, BRIAN ; VERSELE MATTHIAS LUC AIME</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN114213415A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BERTHELOT DIDIER JEAN-CLAUDE</creatorcontrib><creatorcontrib>SCHOENJES, BRUNO</creatorcontrib><creatorcontrib>DIELS GASTON STANISLAS MARCELLA</creatorcontrib><creatorcontrib>VIELEVOYE, MARC</creatorcontrib><creatorcontrib>MIPOY, LAURENT</creatorcontrib><creatorcontrib>EMBRECHTS WERNER CONSTANT JOHAN</creatorcontrib><creatorcontrib>WILLEMS MARC</creatorcontrib><creatorcontrib>VROBROWSKI, BRIAN</creatorcontrib><creatorcontrib>VERSELE MATTHIAS LUC AIME</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BERTHELOT DIDIER JEAN-CLAUDE</au><au>SCHOENJES, BRUNO</au><au>DIELS GASTON STANISLAS MARCELLA</au><au>VIELEVOYE, MARC</au><au>MIPOY, LAURENT</au><au>EMBRECHTS WERNER CONSTANT JOHAN</au><au>WILLEMS MARC</au><au>VROBROWSKI, BRIAN</au><au>VERSELE MATTHIAS LUC AIME</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Macrocyclic pyrimidine derivatives</title><date>2022-03-22</date><risdate>2022</risdate><abstract>The present invention relates to substituted macrocyclic pyrimidine derivatives of formula (I) wherein the variables have the meanings defined in the claims. The compounds according to the present invention have EF2K inhibitory activity and optionally also Vps34 inhibitory activity. The invention further relates to processes for the preparation of such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.
本发明涉及具有式(I)的取代的大环嘧啶衍生物其中变量具有在权利要求中所定义的含义。根据本发明的化合物具有EF2K抑制活性以及任选地还有Vps34抑制活性。本发明进一步涉及用于制备此类新颖化合物的方法、包括所述化合物作为活性成分的药物组合物连同所述化合物作为药剂的用途。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN114213415A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Macrocyclic pyrimidine derivatives |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T02%3A55%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BERTHELOT%20DIDIER%20JEAN-CLAUDE&rft.date=2022-03-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN114213415A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |